Glaucoma Surgery Devices Market Size, Share, Growth Analysis, By Product(Glaucoma drainage devices, glaucoma laser systems), By End-User(Hospitals, ophthalmic clinics) - Industry Forecast 2024-2031

Glaucoma Surgery Devices Market size was valued at USD 339.18 million in 2021 and is poised to grow from USD 530.13 million in 2022 to USD 3.19 million by 2030, at a CAGR of 25.14% during the forecast period (2023-2030).

The competitive landscape of the glaucoma surgery devices market is characterized by the presence of several key players striving to gain a competitive edge and expand their market share. These companies are focused on research and development activities to introduce innovative and technologically advanced glaucoma surgery devices. They are also engaged in strategic collaborations, partnerships, and mergers and acquisitions to strengthen their product portfolios and expand their geographic presence. Furthermore, market players are actively involved in marketing and promotional activities to create awareness about their products and gain traction among healthcare professionals and patients. 'Alcon Inc. (Switzerland)', 'Abbott Laboratories (US)', 'Carl Zeiss Meditec AG (Germany)', 'Johnson & Johnson Vision (US)', 'Bausch Health Companies Inc. (Canada)', 'Novartis AG (Switzerland)', 'Glaukos Corporation (US)', 'Ellex Medical Lasers Limited (Australia)', 'Allergan, Inc. (Ireland)', 'Topcon Corporation (Japan)', 'Lumenis Ltd. (Israel)', 'NIDEK Co., Ltd. (Japan)', 'Santen Pharmaceutical Co., Ltd. (Japan)', 'AqueSys, Inc. (US)', 'Iridex Corporation (US)', 'OCULUS Optikgeräte GmbH (Germany)', 'Molteno Ophthalmic Limited (New Zealand)', 'New World Medical, Inc. (US)', 'Sight Sciences, Inc. (US)', 'Ivantis, Inc. (US)'

The aging population, coupled with lifestyle factors such as increased screen time and prevalence of conditions like diabetes, has contributed to a growing incidence of glaucoma. This surge in glaucoma cases has led to a higher demand for effective surgical interventions, driving the market for glaucoma surgery devices. Healthcare providers and patients are recognizing the importance of early detection and treatment of glaucoma, further fueling the demand for surgical devices.

Growing Emphasis on Combination Therapies: Another notable trend in the glaucoma surgery devices market is the increasing emphasis on combination therapies. Combining different treatment modalities, such as medications, laser therapy, and surgical interventions, can provide synergistic effects and better control of intraocular pressure (IOP). The integration of glaucoma surgery devices with drug-delivery systems, such as sustained-release implants, enables targeted and controlled drug administration, enhancing the effectiveness of treatment.

The largest market region in the glaucoma surgery devices market is North America. North America has a well-established healthcare infrastructure, advanced medical facilities, and high healthcare expenditure, contributing to the dominant position of this region in the market. The presence of key market players and their strong distribution networks further bolsters the market in North America. Additionally, the region has a high prevalence of glaucoma, primarily attributed to an aging population and lifestyle factors, leading to a significant patient pool requiring surgical interventions. Moreover, favorable reimbursement policies and government initiatives aimed at reducing glaucoma-related blindness contribute to the growth of the glaucoma surgery devices market in North America.